All our reports

Filter by

Reset filter
March 3, 2023 Report

Acute Myeloid Leukemia (AML) - Global Clinical Trial Landscape-Focus on Asia Pacific

Asia Pacific accounted for approximately 46,000 AML cases in 2020, with China, India, and Japan accounting for 40% of the global cases.

Download
February 20, 2023 Report

Rheumatoid arthritis– Global Clinical trial landscape- Focus on Asia Pacific

India and China show the highest prevalence of Rheumatoid arthritis, with 10 million and 5 million cases respectively, with the most rapidly growing age-standardized incidence and prevalence rates

Download
January 19, 2023 Report

Alzheimer’s Disease

Alzheimer’s disease is the most common cause of dementia, and the Asia Pacific region is expected to contribute to more than half of all global dementia cases by 2030.

Download
January 9, 2023 Report

Idiopathic Pulmonary Fibrosis - Asia Pacific – Clinical Trial Landscape

The global burden of IPF is expected to rise, due to the rapidly aging population of Asia Pacific region, with South Korea, in particular, having the highest incidence and prevalence rates of IPF.

Download
December 16, 2022 Report

Chronic Obstructive Pulmonary Disease (COPD)-Asia Pacific- Clinical trial landscape

The Asia-Pacific region had a COPD prevalence rate of 13.5% in 2019, exceeding the global average, with Mainland China showing the highest prevalence.

Download
December 8, 2022 Report

Peanut Allergy Asia Pacific – Clinical trial landscape

Similar to the west, Australia in the APAC region has the highest rate of peanut allergy affecting around 3% of children.

Download
November 25, 2022 Report

Glaucoma Asia Pacific – Clinical trial landscape

Owing to a large and ageing population base, Asia accounts for more than 60% of the estimated global cases of glaucoma.

Download
November 18, 2022 Report

Diabetic Retinopathy Asia Pacific – Clinical Trial Landscape

Asia-Pacific region accounts for 51% of all blindness cases and 56% of cases of visual impairment worldwide due to Diabetic Retinopathy

Download
October 12, 2022 Report

Paroxysmal nocturnal hemoglobinuria (PNH)

According to estimates, 1-2 cases per million people develop PNH annually in Western nations, while the rate is roughly 10 per million each year in Asia, with China and India showing the highest in

Download
October 10, 2022 Report

C3 Glomerulopathy (C3G)

From 1990 to 2019, Asia, particularly South Asia experienced the greatest increase in age-standardized incidence and prevalence rates of Glomerulonephritis compared to the West.

Download
September 29, 2022 Report

Bile duct cancer (Cholangiocarcinoma) Asia Pacific – Clinical Trial Landscape

Asia has a significantly greater prevalence of Cholangiocarcinoma, in comparison to the other parts of the world, with China, South Korea, Thailand, and Taiwan having the highest incidence rates in

Download
September 27, 2022 Report

Ulcerative colitis asia pacific – clinical trial landscape

UC incidence and prevalence have rapidly increased in Asia over the past four decades, particularly in Australia and Japan

Download
September 1, 2022 Report

Non-alcoholic steatohepatitis (NASH) Asia Pacific – Clinical trial landscape

Asia accounted for nearly 15% of the overall prevalence of Clostridium difficile infection with a death rate nearing 10% in 2019.  

Download
September 1, 2022 Report

Clostridium Difficile Infection (CDI) Asia Pacific – Clinical Trial Landscape

Asia accounted for nearly 15% of the overall prevalence of Clostridium difficile infection with a death rate nearing 10% in 2019.

Download
August 22, 2022 Report

Diffuse large b-cell Lymphoma – Asia Pacific – Clinical trial landscape

Asia accounted for nearly 70% of the global incidence of DLBCL in 2020, with Mainland China, India, and Japan contributing to a third of all DLBCL cases worldwide.

Download
August 2, 2022 Report

Brain/central nervous System (cns) tumors – Asia pacific – clinical Trial landscape

Asia accounted for more than 50% of the global incidence of brain and CSN tumor in 2020, with Mainland China, India, and Japan contributing to majority of the cases.

Download
July 28, 2022 Report

Psoriasis - Asia Pacific –Clinical Trial Landscape

Of the approximately 30 million adult Psoriasis cases that were prevalent globally in 2017, the highest prevalences were found in the Asian region particularly India, Mainland China, and Japan.

Download
July 27, 2022 Report

Solid tumors - Asia Pacific – Clinical trial Landscape

There were over 8.2 million new cases and over 5 million deaths due to solid cancers in Asia, with the region accounting for half of the new cancer cases and 60% of the world’s deaths in 2020.

Download
July 13, 2022 Report

Multiple myeloma - Asia pacific – clinical Trial landscape

Multiple myeloma cases are increasing in Asia, with the region currently contributing to more than 35% of the projected global incidence, with China, India, and Japan comprising more than a quarter

Download
July 13, 2022 Report

Covid-19 - asia pacific – Clinical trial landscape

Asia Pacific accounts for around 20% of the total COVID-19 cases reported globally with Taiwan, Australia, Japan, and South Korea reporting the highest number of new cases of COVID-19 in the region

Download
June 22, 2022 Report

Parkinson’s disease - Asia pacific – clinical Trial landscape

Due to the presence of half of the world’s aging population and a high population growth rate in APAC, the global burden of Parkinson's Disease is expected to rise, with China, Japan, and India col

Download
June 15, 2022 Report

Acute pancreatitis – Asia pacific – clinical Trial landscape

Owing to its huge, aged population base, Asia accounts for over 55% of the estimated global incidence of Acute pancreatitis, with China, Japan, and India collectively contributing to over a quarter

Download
June 15, 2022 Report

Chronic pain - Asia pacific – clinical Trial landscape

In Asia Pacific, Chronic Pain affects more than half of the population, with China and India together contributing close to 700 million cases.

Download
May 26, 2022 Report

Follicular lymphoma - Asia pacific - clinical Trial landscape

Owing to its large population base, Asia may account for over 40% of the estimated global incidence of Follicular Lymphoma, with China, Japan and India collectively contributing to over a quarter o

Download
May 26, 2022 Report

Atopic dermatitis

Asia has been witnessing increasing levels of Atopic Dermatitis (AD) over the previous few decades, with the Paediatric AD prevalence rates in various Asian ethnicities reaching as high as 20%.

Download
May 24, 2022 Report

Renal Cell Carcinoma

Owing to its large population base, Asia accounts for over 35% of the estimated global incidence of Renal cell carcinoma, with China, Japan, and India collectively contributing to over a quarter of

Download
March 31, 2022 Report

Triple negative breast Cancer

With a high population density and over 45% of the global breast cancer incidence, Asia is expected to account for more than half of all TNBC cases, with a large TNBC patient pool, particularly in

Download
March 17, 2022 Report

Disease report - CKD - APAC - CT Landscape

Diabetes and hypertension are expected to drive the global prevalence of CKD, with much of this increasing burden observed in Asian locations of China and India.

Download
March 14, 2022 Report

Hepatitis B - Asia Pacific - Clinical trials Landscape

The Asia-Pacific with an intermediate to high prevalence, represents three-quarters of chronic hepatitis B (CHB)-positive subjects worldwide.

Download
February 24, 2022 Report

Small cell lung cancer

Each year, there are over 300,000 new cases of Small Cell Lung Cancer globally, with Asia accounting for nearly 60% of the cases.

Download
February 3, 2022 Report

Prostate cancer

Asia ranks second in Prostate cancer incidence accounting for over a quarter of the global incident cases and has the world’s highest number of deaths due to Prostate cancer in 2020.

Download
January 21, 2022 Report

Bladder cancer

Asia accounted for over a third of the global bladder cancer incidence with over 200,00 newly diagnosed cases, with China having a higher prevalence of bladder cancer in 2020.

Download
January 21, 2022 Report

Thyroid cancer

Asia accounted for almost 60% of the global incidence, mortality and five-year prevalence in 2020, with the highest incidence rates found in Australia and Eastern Asia for both sexes.

Download
December 17, 2021 Report

Cervical cancer Asia pacific Clinical trial landscape

Asia accounts for almost 60% of the global incidence of cervical cancer, with India and China together contributing to more than a third of all cases and deaths.

Download
December 17, 2021 Report

Pancreatic cancer Clinical trials landscape Asia pacific

The incidence of pancreatic cancer is rising in Asia-Pacific, with the region accounting for about half of new cases in 2020.

Download
December 17, 2021 Report

Gastric cancer Clinical trial landscape Asia-pacific

Nearly 75% of the new gastric cancer cases in the world are concentrated in Asia, with China showing the highest incidence and mortality.

Download
November 29, 2021 Report

Colorectal cancer clinical trials landscape asia pacific

The incidence of colorectal cancer cases is rapidly growing in Asia-Pacific and the region now accounts for more than half of all new cases diagnosed globally.

Download
November 29, 2021 Report

Lung cancer (nsclc) clinical trials landscape asia pacific

In Asia, lung cancer ranks as the most prevalent cancer and the primary cause of mortality, with the region accounting for almost 60% of the global incidence of lung cancer.

Download
November 3, 2021 Report

Esophageal cancer – Clinical trials landscape – Asia pacific

In Asia, EC is the sixth most common cancer, with the region constituting almost 80% of the new EC cases globally. The highest standardized incidence rate has been observed in East Asia.

Download
October 14, 2021 Report

Clinical trial landscape Of cll in asia-pacific

CLL is one of the most common forms of leukaemia, with the Asia Pacific region showing increasing incidence. China and South Korea are among the Asian locations showing the greatest incidence.

Download
October 12, 2021 Report

Clinical trial landscape of Liver cancer in asia pacific

According to the Globocan 2020 report, liver cancer is the fourth most frequent cancer in Asia, with the region accounting for over 70% of all new liver cancer cases worldwide.

Download
September 17, 2021 Report

Clinical trial landscape of diabetes (type 2) in asia-pacific

Diabetes, which is endemic in most Western countries, is now seeing a surge in developing nations across Asia due to aging, urbanization, and changing dietary habits.

Download
September 17, 2021 Report

Clinical trial landscape of endometrial cancer in asia-pacific

In 2020, Globocan reported over 400,000 new corpus uteri cases, with Asia accounting for about 40% of these new cases.

Download
August 27, 2021 Report

Clinical trial landscape of B-cell lymphoma in asia-pacific

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common and the most aggressive subtype constituting nearly 70% of B-Cell Lymphomas in Asia.

Download
August 20, 2021 Report

Clinical trial landscape of t-cell lymphomas in asia-pacific

T-cell lymphomas (TCLs) are types of non-Hodgkin’s lymphoma (NHL) that affect T lymphocytes.

Download
August 18, 2021 Report

Cystic fibrosis-Clinical Trials Landscape-APAC

Cystic fibrosis is a rare autosomal recessive disease which primarily affects the lungs and digestive system due to a malfunction in the exocrine system responsible for producing saliva, sweat, tea

Download
February 15, 2021 Report

AML Landscape in Asia-Pacific

AML is the most common form of leukemia in adults, accounting for approximately a third of all leukemia cases worldwide.

Download
February 15, 2021 Report

Ovarian Cancer Landscape in Asia-Pacific

Ovarian cancer is the 7th most common cancer and 8th leading cause of cancer mortality among women globally.

Download
February 15, 2021 Report

NHL Landscape in Asia-Pacific

Lymphoma, including Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL), is one of the most common cancers worldwide.

Download
February 15, 2021 Report

Melanoma Landscape in Asia-Pacific

Cancer of the skin is by far the most common of all cancers. Melanoma accounts for only about 1% of skin cancers but causes a large majority of skin cancer deaths.

Download
February 15, 2021 Report

H&N Cancer Landscape in Asia-Pacific

Head and neck cancer (HNC) is the sixth most common cancer globally, with the highest incidence being observed in the Asia region.

Download
February 15, 2021 Report

Breast Cancer Landscape in Asia-Pacific

  Breast cancer is the most frequent cancer, impacting 2.1 million patients each year, and causes the greatest number of cancer-related deaths.

Download
February 28, 2020 Report

Regulatory requirements for clinical trials in Australia

With a streamlined regulatory environment, including no requirement for an IND, and the supportive R&D Government refund of up to 43.5% on clinical research spend, Australia has become a prefer

Download
February 5, 2020 Report

Accelerating Genetic Therapy Clinical Trials in Asia-Pacific

A growing number of biotechnology companies, both in the West and in Asia, are specializing in gene therapies and other regenerative treatments boosted by the approval of the first genetic therapy

Download
February 4, 2020 Report

Accelerating Immunotherapy Clinical Trials in Asia-Pacific

Over 600 sites across Asia-Pacific have been involved in the clinical development of now approved IO drugs, and hundreds more are experienced in managing clinical trials with immunotherapies for bo

Download
December 1, 2019 Report

Orphan drug trials accelerating in Asia Pacific

We have observed an unprecedented effort in the clinical development of Orphan drugs in the recent years.

Download